Agenda

Due to possible spacing needs, agenda times might shift to accommodate. Please check the website for regular updates.

Displaying agenda in the event’s time zone (CEST, GMT +1)

MASTERCLASSES
Tuesday, 16 April, 2024
CONFERENCE DAY 1
Wednesday, 17 April, 2024
CONFERENCE DAY 2
Thursday, 18 April, 2024

Registration & Welcome Coffee in Exhibition Hall

Opening Remarks from Chairpersons

Presented by Boehringer Ingelheim and Novartis Pharma AG

Keynote: Convergence of the Newest, State-of-the-Art AI and Longevity R&D

In my forthcoming talk, I will delve into the latest advancements in artificial intelligence, highlighting revolutionary concepts such as neural-symbolic AI, decentralized AI, and the formation of the Artificial Superintelligence Alliance.

I aim to elucidate how these innovative developments are poised to transform Pharma Research & Development, offering a deep dive into the concept of a ‘Bioatomspace.’ This segment will demonstrate the application of AI in studying human longevity, focusing on the integration of diverse model organism data within these AI frameworks. A core thesis of my presentation is the pivotal role of contemporary AI breakthroughs in reshaping the R&D arena. I will argue that entities not embracing this technological evolution risk obsolescence, underscoring the imperative for immediate and strategic adaptation in the face of this paradigm shift.

Presented by Rejuve.Bio

Keynote: From Insights to Impact: Revolutionizing Pharma Market Research and CI with Actionable Data and Innovative Ways of Working

Presented by Janssen

Networking and Refreshments in Exhibition Hall

Keynote: The Importance of Early Strategic Planning for Global Success

At its core, it is critical for pharma companies to keep their global commercial strategies in mind way ahead of commercial launch and integrate them into the R&D pipeline programs at every step.

In today’s complex healthcare ecosystem when the local regulatory authorities have numerous nuances, it is important to think beyond the regulatory and clinical trial perspective to improve a product’s probability of success in the global markets. Investing in product planning at very early stages has earned greater prominence in recent years. Through this session, we would like to share Molekule Consulting’s perspectives on the key factors to success to win the global markets.

Presented by Molekule Consulting

How to Conduct Competitive Simulation Workshops Effectively and Efficiently: Lessons From Industry

Competitive simulation workshops are a powerful and diverse tool at the disposal of any CI function. In this presentation we will outline the basic elements that are key to any successful CI workshop. Using examples from our experiences at Servier, and in collaboration with our vendors Lifescience Dynamics, we will describe some recent successes we’ve had in conducting CI workshops with minimal notice but maximum impact and value.

Presented by Lifescience Dynamics

Keynote: Generics & Biosimilars – Important learnings from real world case studies

This session highlights innovative approaches leveraged by generic and biosimilars to speed up market entry. Specifically, this presentation will enable you to

1. Advance your understanding of core regulatory routes, timelines and strategies
2. Understand core Gx/biosimilar product development and entry strategies
3. Learn from & set up a best-in-industry Gx/biosimilar regulatory intelligence (RI) and CI tracking program
The presentation will be supported by thought provoking real-world case studies to stress differences between theory vs actual approaches

Presented by INOVIS

Networking Luncheon

Slicing Through the Complexity of Solid Tumor Trials with SLICER: Innovative Approaches in Trial Analysis

CT.gov language for solid tumor trials is often ambiguous and non-standardized, turning landscaping efforts into a nightmare of trial record interpretation and manual annotation.

By examining various approaches, including studying the accuracy of advanced NLP technologies, we reimagine how to efficiently conduct pan-tumor and detailed trend analyses in solid tumor trials. Don’t miss this session if your CI and strategy teams need augmented data sets beyond the unstructured nature of clinical trial records.

Presented by Fenix

CI and the Quest for the Single Source of Truth

The holy grail of the competitive intelligence world in pharma is access to a single source of truth. That one place - a dashboard or app - where you can go to get a clear, concise and accurate view of the market you are focused on.

What’s in your competitor’s pipeline? How are their trials progressing? Who is on the cusp of a merger that will increase their funding and how will this impact your business?

The thing is, an infallible single source of truth is not realistic. But how close can we get? In this session, Alex Bour will investigate the elements that would make up a single source of truth. He’ll address key questions that CI professionals need to ask as they embark on their quest and share guidance on what to look for in the answers.
– How do we conduct an effective business analysis of competitors in our space to spot key opportunities and threats?
– How can I find out how well our pipeline/ asset/ portfolio stacks up against the competition and where will the biggest competitive threats come from?
– What’s the most efficient way to stay on top of market events and catalysts, with industry-leading analyst perspective, implications, recommendations?

Presented by Evaluate

Integrating Insights with Customer Perspectives

Presented by Prescient

Networking and Refreshments in Exhibition Hall

Maximizing Pharma Intelligence with Integrated Primary & Secondary CI

Navigate the dynamic pharmaceutical landscape with integrated Competitive Intelligence (CI) strategies, leveraging AI chatbots like ChatGPT and advanced data crawling tools. Blend primary and secondary data for a holistic view, empowering strategic decision-making. Join us to explore: · How integrated CI fuels adaptability, opportunities and confident navigation in the pharmaceutical industry · Dive deep into the science of data triangulation · Uncover insights from diverse sources: secondary research, medical gatherings, KOL inputs and industry perspectives

Presented by WNS and Bayer

New Artificial Intelligence Legislation in EU – How will it impact the Pharma Industry

Presented by GlaxoSmithKline

Unleashing the power of social media listening to obtain market and brand insights

In this talk we explore the transformative impact of social media on the pharmaceutical sector. Learn how competitive intelligence and market research can harness the potential of social media to identify trends, engage with influencers, and navigate the dynamic landscape of the industry. Discover how to stay ahead in the competitive pharmaceutical market with strategic insights and actionable data obtained from active and passive social media listening.

Presented by Lifescience Dynamics

Cocktail Reception and Networking

Registration & Welcome Coffee in Exhibition Hall

Opening Remarks from Chairpersons

Presented by Boehringer Ingelheim and Novartis Pharma AG

Keynote: Futureproof your commercial strategy with AI and human expertise to overcome uncertainty

• Learn how top pharma leaders navigate future scenarios with AI to avoid relying on guesswork that can produce costly missteps

• Explore how the combination of AI augmentation and human expertise is revolutionizing agile, cross-functional decision-making
• Work with future-looking insights from real-time data streams to sidestep hidden pitfalls to ensure long-term success

Presented by Atacana Group

Keynote: Hey FENIX, We Need Better CI Tools, Can Genny Help?

In 2023, FENIX unveiled two of its tech offerings - HeyFENIX and Project Genny. In this session, FENIX will provide a new update from 2023 about our latest tools for enhancing CI workflows using natural language processing (NLP) and a contextually trained generative AI model.

Importantly, both solutions match stakeholder behaviors and are simple to integrate. FENIX will focus on the stakeholder archetypes that benefit most and how our technology aligns with their business objectives. Finally, FENIX will demonstrate how these vital integrations can optimize asynchronous CI data retrieval and realize all efficiencies imaginable.

Presented by Fenix

Networking and Refreshments in Exhibition Hall

Predicting Drug Approvals: A Neural Network Approach

Neural networks, when combined with Kognitic’s AI NLPs, can analyze vast clinical trial datasets to identify the patterns within. Kognitic has developed a revolutionary, deep-learning model to predict drug launch dates, factoring in dynamic factors, such as protocol changes. Discover how Kognitic empowers our partners' CI decision-making.

Presented by Kognitic

Is My AI Better than your AI?

Presented by Dig Worldwide

20 Years of CI: The Development and Impact of Provider to Partner, and What Will Be the Key Challenges and Opportunities for the Future?

Presented by Deallus

Networking Luncheon

“Ask the Experts” Interactive Round Tables

(Explore and capture the power of participants’ Insights and experiences and exploration of these topics in this fun and informal environment in small groups.)
ROUND TABLE 1
The Application of AI in Pharma Market Research

Presented by Boehringer Ingelheim

ROUND TABLE 2
What is the Right Place for CI in the Pharma Organization?

Presented by Chiesi Farmaceutici S.p.A.

ROUND TABLE 3
Macro Trends in Pharma and Biotech

Presented by Pfizer

“Ask the Experts” Interactive Round Tables

(Explore and capture the power of participants’ Insights and experiences and exploration of these topics in this fun and informal environment in small groups.)
ROUND TABLE 1
Data Analysis and Forecasting

Presented by Pfizer

ROUND TABLE 2
From Local to Global and Vice-Versa: Managing Interests, Threats and Insights

Presented by Chiesi Farmaceutici S.p.A.

ROUND TABLE 3
Knowledge Management in CI
• Emphasize and discuss how knowledge management fosters innovation by creating a culture of knowledge sharing and collaboration among teams.
• Highlight the role of knowledge management tools and platforms in facilitating cross-functional collaboration for CI activities.

Presented by Boehringer Ingelheim

Announcement of Stamp Card & Raffle Prize Winners

CI and KM in the next world

Collaborative Intelligence, transmission, decision support and innovation, culture of continuous learning... In an environment in perpetual transformation, Competitive Intelligence and knowledge management is more than ever a strategic asset.

But exactly what challenges does CI and KM have to overcome in a changing our industry? How can we capitalize on experience and skills when the hybridization of work, the “great resignation” and turnover disperse the CI channels and weaken the transmission of knowledge internally?

If the tools are there, they are sometimes too numerous or poorly used. As Servier has just begun the reengineering of its CI&KM organization, we can walk the attendance through some key learnings coming from this transformation journey and how to navigate avoiding the mermaids of new technologies!

Presented by Servier

The Life and Times of Pharma CI

Closing Remarks from Chairpersons

Presented by Boehringer Ingelheim and Novartis Pharma AG

Registration and Welcome Coffee

Synthesizing Primary Research Into Actionable Insights and Presentations

When it comes to gaining valuable insights from primary research, the challenge lies in synthesizing research data and drawing actionable insights to achieve your research objectives. The Molekule team will highlight the key considerations in designing primary research projects, synthesizing actionable insights from collected data, and articulating key findings into impactful and strategic presentations leading to a shared understanding.

Presented by Molekule Consulting

Coffee Break

KITting and KIQing: The nuts, bolts, and tools that make the CI machine run

Learn the art and science behind crafting intelligent questions to uncover the competitive insights your business needs to stay ahead. In this hands-on exercise you’ll design questions and solve problems for a fictional company. This interactive workshop focuses on question methodology that cuts through noise to get quality answers out of your intelligence projects.

Presented by Lifescience Dynamics

Networking Lunch

Developing a Competitive Activity Framework to Enhance Organizational Competitiveness

This workshop session will give participants first-hand insights from a combined 30+ years of experience in delivering strategic and tactical workshop-style solutions, using an optimal blend of established CI frameworks alongside INOVIS’ proprietary methodologies.

Key to this session will be addressing business needs across the lifecycle, whereby participants will:
• Develop an in-depth understanding of how a diverse range of facilitated activities (Rapid Immersion, Threat Assessment and Competitor Simulations) can help deliver strategic and competitive insights within an organization
• Appreciate the importance of leveraging the outcomes of workshops to inform and direct decision making
• Receive hands-on opportunities to apply learnings to a pharma case-study in a learning environment
Using business case studies, real-life experiences and validated theory, the INOVIS team will equip you with a number of go-to techniques that can be rapidly integrated into ongoing CI Practice, whether you’re a seasoned CI professional veteran, or newer to the field.

Presented by INOVIS

Coffee Break

Sense Making with AI in the Data Age

This Masterclass on Sense Making with AI offers a comprehensive exploration into leveraging artificial intelligence (AI) tools and methodologies to extract valuable insights, make informed decisions, and navigate complexity with clarity.

Developed by industry experts and thought leaders at the forefront of AI innovation, this Masterclass delves into the intersection of human cognition and machine intelligence. Participants will embark on a journey to understand how AI technologies can augment human capabilities in sense making, enabling them to unravel intricate patterns, detect trends, and glean actionable intelligence from data-rich environments.

Presented by Atacana Group

Masterclasses Conclude